Modular nanoarray vaccine for SARS-CoV-2

被引：0
|
作者：
Zagorski, Karen [1 ]
Pandey, Kabita [2 ,3 ]
Rajaiah, Rajesh [2 ]
Olwenyi, Omalla A. [2 ,3 ]
Bade, Aditya N. [2 ]
Acharya, Arpan [2 ]
Johnston, Morgan [2 ]
Filliaux, Shaun [1 ]
Lyubchenko, Yuri L. [1 ]
Byrareddy, Siddappa N. [2 ,3 ,4 ,5 ,6 ]
机构：
[1] Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha,NE,68198-6025, United States
[2] Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha,NE, United States
[3] Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha,NE, United States
[4] Department of Genetics, Cell Biology, and Anatomy, University of Nebraska Medical Center, Omaha,NE, United States
[5] Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha,NE, United States
[6] Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
来源：
Nanomedicine: Nanotechnology, Biology, and Medicine | 2022年 / 46卷
关键词：
Compendex;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Coronavirus
引用
下载
收藏
相关论文
共 50 条
  • [31] Immune imprinting and SARS-CoV-2 vaccine design
    Wheatley, Adam K.
    Fox, Annette
    Tan, Hyon-Xhi
    Juno, Jennifer A.
    Davenport, Miles P.
    Subbarao, Kanta
    Kent, Stephen J.
    TRENDS IN IMMUNOLOGY, 2021, 42 (11) : 956 - 959
  • [32] Eosinophilic Pneumonia Associated to SARS-CoV-2 Vaccine
    Costa e Silva, Margarida
    Sa Marques, Marta
    Joao, David
    Campainha, Sergio
    ARCHIVOS DE BRONCONEUMOLOGIA, 2022, 58 : 51 - 52
  • [33] SARS-CoV-2 vaccine candidates in rapid development
    Li, Lifeng
    Guo, Pengbo
    Zhang, Xiaoman
    Yu, Zhidan
    Zhang, Wancun
    Sun, Huiqing
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (03) : 644 - 653
  • [34] Vitiligo Repigmentation After SARS-CoV-2 Vaccine
    Bustos-Macaya, Roberto
    Gonzalez-Coloma, Francisco
    Morales-Etcheberry, Juan Pablo
    Segovia, Laura
    DERMATOLOGY PRACTICAL & CONCEPTUAL, 2023, 13 (04):
  • [35] Predictors of the intention to receive a SARS-CoV-2 vaccine
    Meier, Brian P.
    Dillard, Amanda J.
    Lappas, Courtney M.
    JOURNAL OF PUBLIC HEALTH, 2022, 44 (03) : 713 - 715
  • [36] Platforms Exploited for SARS-CoV-2 Vaccine Development
    Mathew, Shilu
    Faheem, Muhammed
    Hassain, Neeraja A.
    Benslimane, Fatiha M.
    Al Thani, Asmaa A.
    Zaraket, Hassan
    Yassine, Hadi M.
    VACCINES, 2021, 9 (01) : 1 - 24
  • [37] Development of SARS-CoV-2 Vaccine: Challenges and Prospects
    Mahboob, Tooba
    Ismail, Amni Adilah
    Shah, Muhammad Raza
    Rahmatullah, Mohammed
    Paul, Alok K.
    Pereira, Maria de Lourdes
    Wiart, Christophe
    Wilairatana, Polrat
    Rajagopal, Mogana
    Dolma, Karma G.
    Nissapatorn, Veeranoot
    DISEASES, 2023, 11 (02)
  • [38] The Improbability of the Rapid Development of a Vaccine for SARS-CoV-2
    Morris, Kevin V.
    MOLECULAR THERAPY, 2020, 28 (07) : 1548 - 1549
  • [39] LYMPHOHISTIOCYTIC MYOCARDITIS FOLLOWING SARS-COV-2 VACCINE
    Sharma, Arushi
    Shah, Shanil
    Venkataramanan, Sai Vikram Alampoondi
    Dai, Qiying
    Hadley, Michelle L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 3384 - 3384
  • [40] Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile
    Jara, Alejandro
    Undurraga, Eduardo A.
    Gonzalez, Cecilia
    Paredes, Fabio
    Fontecilla, Tomas
    Jara, Gonzalo
    Pizarro, Alejandra
    Acevedo, Johanna
    Leo, Katherine
    Leon, Francisco
    Sans, Carlos
    Leighton, Paulina
    Suarez, Pamela
    Garcia-Escorza, Heriberto
    Araos, Rafael
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (10): : 875 - 884
12345